|
| 37973290 | Walter Bauer, Marian Wilkins Ropes, and the Massachusetts General Hospital. | | 2024 |
| 37827694 | EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. | Ann Rheum Dis | 2024 |
| 34962100 | Evaluating the Construct of Damage in Systemic Lupus Erythematosus. | Arthritis Care Res (Hoboken) | 2023 |
| 36177676 | Belimumab use during pregnancy: Interim results of the belimumab pregnancy registry. | Birth Defects Research | 2023 |
| 36198440 | Belimumab use during pregnancy: a summary of birth defects and pregnancy loss from belimumab clinical trials, a pregnancy registry and postmarketing reports. | Annals of the Rheumatic Diseases | 2023 |
| 36421035 | Coronary plaque progression is greater in systemic lupus erythematosus than rheumatoid arthritis. | Coron Artery Dis | 2023 |
| 37604638 | Safety profile of baricitinib in patients with systemic lupus erythematosus: an integrated analysis. | | 2023 |
| 37640450 | 2023 ACR/EULAR antiphospholipid syndrome classification criteria. | Ann Rheum Dis | 2023 |
| 36714913 | Effect of Systemic Lupus Erythematosus and Immunosuppressive Agents on COVID-19 Vaccination Antibody Response. | | 2023 |
| 37085289 | Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes. | Ann Rheum Dis | 2023 |
| 37208152 | Systemic Lupus Erythematosus Women with Lupus Nephritis in Pregnancy Therapeutic Challenge (SWITCH): The Systemic Lupus International Collaborating Clinics experience. | Ann Rheum Dis | 2023 |
| 37147022 | Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks. | | 2023 |
| 36704930 | Fluctuation of Anti-Domain 1 and Anti-β<sub>2</sub> -Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies. | Arthritis Rheumatol | 2023 |
| 37459273 | Association Between Severe Nonadherence to Hydroxychloroquine and Systemic Lupus Erythematosus Flares, Damage, and Mortality in 660 Patients From the SLICC Inception Cohort. | Arthritis Rheumatol | 2023 |
| 36807703 | Role of Platelet-Bound C4d (PC4d) in Predicting Risk of Future Thrombotic Events in Systemic Lupus Erythematosus. | | 2023 |
| 36941260 | Affinity maturation generates pathogenic antibodies with dual reactivity to DNase1L3 and dsDNA in systemic lupus erythematosus. | | 2023 |
| 36691838 | Assessing the Costs of Neuropsychiatric Disease in the Systemic Lupus International Collaborating Clinics Cohort Using Multistate Modeling. | Arthritis Care Res (Hoboken) | 2023 |
| 37431809 | Analytical validation of urine ALCAM ELISA as a test for lupus nephritis. | | 2023 |
| 36861682 | Reply. | | 2023 |
| 37044248 | Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study. | Lab Invest | 2023 |
| 36848919 | Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II). | | 2023 |
| 36848918 | Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I). | | 2023 |
| 34664621 | History of proliferative glomerulonephritis predicts end stage kidney disease in pure membranous lupus nephritis. | Rheumatology (Oxford) | 2022 |
| 35774777 | Comprehensive Urinomic Identification of Protein Alternatives to Creatinine Normalization for Diagnostic Assessment of Lupus Nephritis. | Frontiers in Immunology | 2022 |
| 36040804 | Alternative exon usage in TRIM21 determines the antigenicity of Ro52/TRIM21 in systemic lupus erythematosus. | JCI insight | 2022 |
| 36038160 | Renal response at 2 years post biopsy to predict long-term renal survival in lupus nephritis: a retrospective analysis of the Hopkins Lupus Cohort. | Lupus Science and Medicine | 2022 |
| 35512816 | One-third of patients with lupus nephritis classified as complete responders continue to accrue progressive renal damage despite resolution of proteinuria. | Lupus Science and Medicine | 2022 |
| 36167482 | Urine proteomic insights from the belimumab in lupus nephritis trial. | Lupus Science and Medicine | 2022 |
| 36017607 | The association of lupus nephritis with adverse pregnancy outcomes among women with lupus in North America. | Lupus | 2022 |
| 35439360 | Impact of Belimumab on Organ Damage in Systemic Lupus Erythematosus. | Arthritis Care Res (Hoboken) | 2022 |
| 36283746 | Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemic. | Lupus Sci Med | 2022 |
| 35947992 | Scoring personalized molecular portraits identify Systemic Lupus Erythematosus subtypes and predict individualized drug responses, symptomatology and disease progression. | Briefings in Bioinformatics | 2022 |
| 35882508 | Short- and Long-Term Progression of Kidney Involvement in Systemic Lupus Erythematosus Patients with Low-Grade Proteinuria. | Clin J Am Soc Nephrol | 2022 |
| 35944946 | Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort. | Ann Rheum Dis | 2022 |
| 35490454 | Drug monitoring in systemic lupus erythematosus. | Current Opinion in Pharmacology | 2022 |
| 36206383 | Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry"). | Lupus | 2022 |
| 35609978 | Mechanism of action of baricitinib and identification of biomarkers and key immune pathways in patients with active systemic lupus erythematosus. | Annals of the Rheumatic Diseases | 2022 |
| 35608258 | The DNA sensors AIM2 and IFI16 are SLE autoantigens that bind neutrophil extracellular traps. | Elife | 2022 |
| 35918102 | Urinary HER2, TWEAK and VCAM-1 levels are associated with new-onset proteinuria in paediatric lupus nephritis. | Lupus Science and Medicine | 2022 |
| 35351810 | Clinical and histopathological features of myositis in systemic lupus erythematosus. | Lupus Science and Medicine | 2022 |
| 36396267 | Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquine. | Lupus Sci Med | 2022 |
| 35914791 | Trajectory of Damage Accrual in Systemic Lupus Erythematosus Based on Ethnicity and Socioeconomic Factors. | Journal of Rheumatology | 2022 |
| 35775881 | Lipoprotein(a) in systemic lupus erythematosus is associated with history of proteinuria and reduced renal function. | Lupus | 2022 |
| 35534786 | Treatment Patterns and Clinical Characteristics of Patients with Systemic Lupus Erythematosus and Musculoskeletal Symptoms: A Retrospective, Observational Study. | Advances in Therapy | 2022 |
| 36569940 | A novel technology for home monitoring of lupus nephritis that tracks the pathogenic urine biomarker ALCAM. | | 2022 |
| 33152181 | Prediction of Hospitalizations in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index. | Arthritis Care Res (Hoboken) | 2022 |
| 33342072 | Predictors of Osteonecrosis in Systemic Lupus Erythematosus: A Prospective Cohort Study. | Arthritis Care and Research | 2022 |
| 35338033 | Longitudinal analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort. | Ann Rheum Dis | 2022 |
| 35318256 | Hydroxychloroquine in the pregnancies of women with lupus: a meta-analysis of individual participant data. | Lupus Sci Med | 2022 |
| 34922324 | Deconvoluting virome-wide antibody epitope reactivity profiles. | EBioMedicine | 2022 |